📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity. (2022)

First Author: Blunt MD

Attributed to: Targeting natural killer cell receptors for immunotherapeutic benefit funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.4049/jimmunol.2101139

PubMed Identifier: 35768150

Publication URI: http://europepmc.org/abstract/MED/35768150

Type: Journal Article/Review

Volume: 209

Parent Publication: Journal of immunology (Baltimore, Md. : 1950)

Issue: 2

ISSN: 0022-1767